Literature DB >> 2297190

The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus.

S J Levine1, D A White, A O Fels.   

Abstract

This study assessed the incidence and clinical significance of recovery of Staphylococcus aureus from the respiratory tract of patients infected with the human immunodeficiency virus (HIV). In a retrospective review of 129 consecutive episodes of respiratory disease in HIV-seropositive patients where respiratory tract cultures were obtained, S. aureus was recovered in 30 (23%) of the episodes. Twenty-nine of these were evaluated in this study, and the recovery of S. aureus was found to represent pneumonia in 8 cases (28%), to be of indeterminate significance in 18 cases (62%), and to represent colonization in 3 cases (10%). Episodes of S. aureus pneumonia were usually community-acquired (seven of eight episodes) and had an acute or subacute clinical presentation. Fever and physical signs of pneumonia were present in all patients. Chest radiographic presentations varied, but local infiltrates were seen in seven of eight episodes. Concomitant pulmonary disorders were common (seven of eight episodes). All patients were appropriately treated; five patients recovered and three died, giving a mortality rate of 38%. We conclude that S. aureus is a frequent isolate from respiratory tract cultures of HIV-seropositive patients referred for evaluation of pulmonary disease. It can cause a pneumonia with a high mortality rate, as it did in 6% of all episodes of pulmonary disease reviewed in this study. Clinicians should be aware that HIV-seropositive patients may develop respiratory disease secondary to S. aureus infection and that when this organism is suspected, appropriate antibiotic therapy should be instituted.

Entities:  

Mesh:

Year:  1990        PMID: 2297190     DOI: 10.1164/ajrccm/141.1.89

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Activation of the human immunodeficiency virus long terminal repeat in THP-1 cells by a staphylococcal extracellular product.

Authors:  S J Klebanoff; F Kazazi; W C Van Voorhis; K G Schlechte
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

Review 2.  AIDS and the lung: update 1995. 2. New developments in the pulmonary diseases affecting HIV infected individuals.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

3.  Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat.

Authors:  A Akashi; S Ono; K Kuwano; S Arai
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells.

Authors:  J E Brinchmann; G Gaudernack; E Thorsby; F Vartdal
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  Health care-associated Staphylococcus aureus pneumonia.

Authors:  Duncan Webster; Linda Chui; Gregory J Tyrrell; Thomas J Marrie
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-05       Impact factor: 2.471

6.  Bronchopulmonary infection with Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.

Authors:  N J Ali; D Kessel; R F Miller
Journal:  Genitourin Med       Date:  1995-04

7.  Characteristics of Drug-Susceptible and Drug-Resistant Staphylococcus aureus Pneumonia in Patients with HIV.

Authors:  Charles K Everett; Anuradha Subramanian; Leah G Jarisberg; Matthew Fei; Laurence Huang
Journal:  Epidemiology (Sunnyvale)       Date:  2013-05-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.